HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,717,701 | -78.0% | 71,144 | -79.2% | 0.01% | -81.4% |
| Q2 2023 | $12,327,427 | -28.7% | 341,764 | -24.6% | 0.04% | -29.5% |
| Q1 2023 | $17,299,459 | +191520.1% | 452,984 | +185.5% | 0.06% | +84.8% |
| Q4 2022 | $9,028 | -98.4% | 158,671 | +1038.6% | 0.03% | +1550.0% |
| Q3 2022 | $551,000 | -10.1% | 13,936 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $613,000 | -38.0% | 13,936 | -43.8% | 0.00% | -33.3% |
| Q1 2022 | $989,000 | -1.2% | 24,793 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $1,001,000 | +8.0% | 24,890 | +9.2% | 0.00% | 0.0% |
| Q3 2021 | $927,000 | -90.8% | 22,788 | -90.3% | 0.00% | -93.2% |
| Q4 2020 | $10,046,000 | – | 235,206 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |